Hundreds of people with multiple myeloma could receive a new, targeted treatment recommended for use within the Cancer Drugs Fund today (Tuesday, 29 October). More evidence is needed on the clinical ...

Initial antibiotic treatment can include amoxicillin ... resistant organisms must be covered as well. Patients with chronic sinusitis often will have developed resistant organisms.

"This could provide a better understanding of the occurrence of chronic cough, which may ultimately result in better treatments for this difficult-to-treat condition." Emilsson and his colleagues ...

(IN BRIEF) GSK plc has announced positive results from its Phase III ANCHOR trials for depemokimab, a biologic treatment for chronic rhinosinusitis with nasal polyps (CRSwNP). The trials demonstrated ...

Chronic rhinosinusitis with nasal polyps has caught the attention of drugmakers since ... Dupixent, which has become one of the pharmaceutical industry’s top-selling drugs, was approved as an add-on ...

The overall incidence and severity of treatment-emergent adverse events ... nasal polyp growth and nasal obstruction.” CRSwNP is a chronic condition that affects up to 4% of the general ...

Nasal congestion treatments include drinking liquids ... Pseudoephedrine: Side Effects, Safety & Uses of Sudafed. UCLA Health. Chronic sinusitis has impacts beyond a runny nose. University of Michigan ...

Millions of Americans suffer from chronic back pain, but for Gene Forrest, the pain became insufferable. “The pain can be so bad it wakes you up from a dead sleep with tears in your eyes ...

According to the National Institutes for Health, chronic sinusitis, also known as chronic rhinosinusitis (CRS), affects approximately 14.6% of the United States population and is currently the fifth ...